Sclerotherapy for leg telangiectasia - A blinded comparative trial of polidocanol and hypertonic saline

Dermatologic Surgery

Volumn 25, Issue 5, 1999, Pages 381-386

  McCoy, Susanne ^a   Evans, Anne ^a   Spurrier, Nicola ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOSIDERIN; LIDOCAINE; POLIDOCANOL; SCLEROSING AGENT; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INJECTION PAIN; LEG DISEASE; MAJOR CLINICAL STUDY; PATIENT SATISFACTION; PHOTOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCLEROTHERAPY; SIDE EFFECT; SINGLE BLIND PROCEDURE; STAINING; TELANGIECTASIA; TREATMENT OUTCOME; VEIN MALFORMATION;

ADULT; FEMALE; HUMANS; HYPERTONIC SOLUTIONS; LEG; MIDDLE AGED; PATIENT SATISFACTION; POLYETHYLENE GLYCOLS; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SINGLE-BLIND METHOD; SODIUM CHLORIDE; TELANGIECTASIS; TREATMENT OUTCOME;

EID: 0033014350     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.1999.08263.x     Document Type: Article

References (13)

1. Goldman MP, Bennett GB. Treatment of telangiectasia: a review. J Am Ac Dermatol 1987;17:167-82.
2. Geux JJ. Indications for the sclerosing agent Polidocanol. J Dermatol Surg Oncol 1993;19:959-61.
3. Goldman P. Polidocanol (Aethoxysclerol) for the sclerotherapy of superficial venules and telangiectasias. J Dermatol Surg Oncol 1989;15:204-9.
4. Goldman MP, Kaplan RP, Oki LN et al. Sclerosing agents in the treatment for telangiectasia: comparison of the clinical and histological effects of intravascular polidocanol, sodium tetradecyl sulfate and hypertonic saline in the dorsal rabbit ear vein model. Arch Dermatol 1987;234:1196-201.
5. Duffy DM. Small vessel sclerotherapy: an overview. Adv Dermatol 1988;3:221-42.
6. Weiss RA, Weiss MA. Incidence of side effects in the treatment of telangiectasia by compression sclerotherapy: hypertonic saline vs. polidocanol. J Dermatol Surg Oncol 1990;16:800-4.
7. Carlin MC, Ratz JL. Treatment of telangiectasia: comparison of sclerosing agents. J Dermatol Surg Oncol 1987;13:1181-3.
8. Foley WT. The eradication of venous blemishes. Cutis 1975;15: 665-8.
9. Bodian EL. Techniques of sclerotherapy for sunburst venous blemishes. J Dermatol Surg Oncol 1985;11:696-704.
10. Sebben JE. Sclerotherapy for telangiectasia of the lower extremity. Dermatol Clin 1989;7:129-35.
11. Goldman MP, Sadick NS, Weiss RA. Cutaneous necrosis, telangiectatic matting and hyperpigmentation following sclerotherapy. Dermatol Surg 1995;21:19-29.
12. Sadick NS. Sclerotherapy of varicose and telangiectatic leg veins: minimal sclerosant concentration of hypertonic saline and its relationship to vessel diameter. J Dermatol Surg Oncol 1991;17:65-70.
13. Sadick NS, Weiss R, Goldman M. The role of compression in the treatment of reticular and telangiectatic leg veins. Proceedings of the XIII World Congress of Phlebology. Sept 1998, Abstract No. O 055.